Becton Dickinson & Co. is recalling approximately 70.8 million BD BBL Sensi Disc units used for antibiotic susceptibility testing due to a risk of inaccurate results. These discs are used by laboratory professionals to determine which antibiotics are effective against H. influenzae bacteria; however, failures in testing accuracy and quality control have been identified. Incorrect results can lead to delayed diagnoses, the selection of inappropriate antibiotics for patients, or extended treatment times. If you have been treated for an infection where these diagnostic tests were used, contact your healthcare provider to discuss your treatment history.
The recalled testing discs may produce inaccurate or failed results when testing H. influenzae, which could lead doctors to prescribe the wrong antibiotic or delay effective treatment for serious infections. This risk of diagnostic error can prolong a patient's illness or lead to adverse medical outcomes due to improper antibiotic exposure.
Validation or discard of product based on diagnostic outcomes
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.